BioArctic Yönetim

Yönetim kriter kontrolleri 2/4

BioArctic CEO'su Gunilla Osswald, Jan2014 tarihinde atandı, in görev süresi 10.83 yıldır. in toplam yıllık tazminatı SEK 22.38M olup, şirket hissesi ve opsiyonları dahil olmak üzere 19.8% maaş ve 80.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.11% ine doğrudan sahiptir ve bu hisseler SEK 14.30M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.8 yıl ve 6.8 yıldır.

Anahtar bilgiler

Gunilla Osswald

İcra Kurulu Başkanı

SEK 22.4m

Toplam tazminat

CEO maaş yüzdesi19.8%
CEO görev süresi10.8yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi5.8yrs
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Aug 15
Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

Apr 13
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 19
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 03
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

Dec 23
Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

Nov 12
With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Jul 21
BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

Jul 15
Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Jul 07
New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

May 06
Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Mar 13
Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

Nov 30
Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

Sep 16
We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

Apr 04
We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

We Think BioArctic (STO:BIOA B) Can Easily Afford To Drive Business Growth

Dec 05
We Think BioArctic (STO:BIOA B) Can Easily Afford To Drive Business Growth

CEO Tazminat Analizi

Gunilla Osswald'un ücretlendirmesi BioArctic'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-SEK 88m

Mar 31 2024n/an/a

-SEK 122m

Dec 31 2023SEK 22mSEK 4m

SEK 229m

Sep 30 2023n/an/a

SEK 259m

Jun 30 2023n/an/a

SEK 270m

Mar 31 2023n/an/a

SEK 327m

Dec 31 2022SEK 9mSEK 5m

-SEK 11m

Sep 30 2022n/an/a

SEK 28m

Jun 30 2022n/an/a

-SEK 147m

Mar 31 2022n/an/a

-SEK 135m

Dec 31 2021SEK 5mSEK 3m

-SEK 120m

Sep 30 2021n/an/a

-SEK 114m

Jun 30 2021n/an/a

-SEK 97m

Mar 31 2021n/an/a

-SEK 101m

Dec 31 2020SEK 5mSEK 3m

-SEK 69m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 60m

Mar 31 2020n/an/a

SEK 78m

Dec 31 2019SEK 7mSEK 3m

SEK 88m

Sep 30 2019n/an/a

SEK 441m

Jun 30 2019n/an/a

SEK 475m

Mar 31 2019n/an/a

SEK 380m

Dec 31 2018SEK 5mSEK 3m

SEK 382m

Sep 30 2018n/an/a

SEK 58m

Jun 30 2018n/an/a

SEK 32m

Mar 31 2018n/an/a

SEK 29m

Dec 31 2017SEK 3mSEK 2m

SEK 15m

Tazminat ve Piyasa: Gunilla 'nin toplam tazminatı ($USD 2.09M ), Swedish pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 873.34K ).

Tazminat ve Kazançlar: Gunilla şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Gunilla Osswald (63 yo)

10.8yrs

Görev süresi

SEK 22,378,000

Tazminat

Dr. Gunilla Osswald, PhD has been the Chief Executive Officer and President of BioArctic AB (publ) since 2014. Dr. Osswald has been a Director of Egetis Therapeutics AB (publ) (formerly known as PledPharma...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Gunilla Osswald
President & CEO10.8yrsSEK 22.38m0.11%
SEK 14.3m
Pär Gellerfors
Co-Founder21.8yrsSEK 390.00kVeri yok
Lars Lannfelt
Co-Founder21.8yrsSEK 2.54m33.41%
SEK 4.5b
Anders Martin-Lof
Chief Financial Officer1.5yrsVeri yokVeri yok
Johanna Fälting
Chief Research Officer & Head of Researchno dataVeri yok0.051%
SEK 6.8m
Christer Möller
VP of Pre-Clinical Development & Chief Scientific Officer18.8yrsVeri yok0.063%
SEK 8.4m
Oskar Bosson
VP and Head of IR & Communication4.5yrsVeri yok0.016%
SEK 2.2m
Leif Gallo
General Counsel and Head of Legal & IPno dataVeri yokVeri yok
Harald Borgeke
Head of Public Affairs2.6yrsVeri yokVeri yok
Frida Lekander
Head of Marketing2.8yrsVeri yokVeri yok
Gunilla Andersson
Vice President of Human Resources5.8yrsVeri yokVeri yok
Mikael Moge
VP & Head of CMCno dataVeri yok0.011%
SEK 1.4m

5.8yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim: BIOA B 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.8 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Pär Gellerfors
Co-Founder21.8yrsSEK 390.00kVeri yok
Lars Lannfelt
Co-Founder21.8yrsSEK 2.54m33.41%
SEK 4.5b
Eugen Steiner
Independent Chairman7.2yrsSEK 621.00k0.10%
SEK 13.5m
Hans Wigzell
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Konrad Beyreuther
Member of the Scientific Boardno dataVeri yokVeri yok
Marie Edström
Independent Director1.4yrsSEK 187.00kVeri yok
Mikael Smedeby
Independent Director6.5yrsSEK 316.00k0.032%
SEK 4.3m
Charlotta Ljungqvist
Independent Director3.5yrsSEK 318.00k0.0036%
SEK 477.3k
Martin Ingelsson
Member of Scientific Boardno dataVeri yokVeri yok
Staffan Pauli
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Ken Marek
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Kaj Blennow
Member of Scientific Advisory Boardno dataVeri yokVeri yok

6.8yrs

Ortalama Görev Süresi

70yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BIOA B 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).